The HIPK2 upregulation in in vitro and in vivo models of diabetic nephropathy unveiled a role of HIPK2 in kidney fibrosis by apoptosis of the renal tubular epithelial cells (RTECs) induced by p53 activation and by HIPK2-induced EMT markers. Here, TP53 is linked to diabetic kidney disease.